Staging nodal disease in non-small cell lung cancer: Implications for radiation therapy

Journal of Thoracic Oncology

Volumn 2, Issue 7, 2007, Pages 585-587

  Senan, Suresh ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER THERAPY; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; HUMAN; LUNG NON SMALL CELL CANCER; MORBIDITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 34547484004     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31807a2fbe     Document Type: Editorial

References (20)

1. Pignon JP, Tribodet GV, Scagliotti G, et al. Lung adjuvant cisplatin evaluation (LACE): a pooled analysis of five randomized clinical trials including 4,584 patients [abstract]. J Clin Oncol 2006;24:366s.
2. Albain KS, Rusch VW, Crowley JJ, et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 1995;13:1880-1892.
3. van Meerbeeck JP, Kramer GW, Van Schil PE, et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst 2007;99:442-450.
4. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-1717.
5. Rusch VW, Crowley J, Giroux DJ, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM Classification for Lung Cancer. J Thorac Oncol 2007;2:XXX-XXX.
6. MacManus MP, Hicks RJ, Matthews JP, et al. High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy. Int J Radiat Oncol Biol Phys 2001;50:287-293.
7. Vergeer MR, Doornaert P, Leemans CR, et al. Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation. Radiother Oncol 2006;79:39-44.
8. Senan S, Chapet O, Lagerwaard FJ, et al. Defining target volumes for non-small cell lung carcinoma. Semin Radiat Oncol 2004;14:308-314.
9. Yuan S, Yu J, Sun X, et al. Three dimensional conformal involved-field RT for stage III NSCLC. J Clin Oncol Proc Am Soc Clin Oncol 2006;24(Suppl):7044.
10. Senan S, DeRuysscher D, Giraud P, et al. Literature-based recommendations for treatment planning and execution for high-precision radiotherapy in lung cancer. Radiother Oncol 2004;71:139-146.
11. Gould MK, Kuschner WG, Rydzak CE, et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med 2003;139:879-892.
12. De Ruysscher D, Wanders S, van Haren E, et al. Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study. Int J Radiat Oncol Biol Phys 2005;62:988-994.
13. de Langen AJ, Raijmakers P, Riphagen I, et al. The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis. Eur J Cardiothorac Surg 2006;29:26-29.
14. Fritscher-Ravens A, Bohuslavizki KH, Brandt L, et al. Mediastinal lymph node involvement in potentially resectable lung cancer: comparison of CT, positron emission tomography, and endoscopic ultrasonography with and without fine-needle aspiration. Chest 2003;123:442-451.
15. Yasufuku K, Nakajima T, Motoori K, et al. Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer. Chest 2006;130:710-718.
16. Lee YC, Wu CT, Kuo SW, et al. Significance of extranodal extension of regional lymph nodes in surgically resected non-small cell lung cancer. Chest 2007;131:993-999.
17. Yuan S, Meng X, Yu J, et al. Determining optimal clinical target volume margins on the basis of microscopic extracapsular extension of metastatic nodes in patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2007;67:727-734.
18. Piet AHM, Lagerwaard FJ, Kunst PWA, et al. Can mediastinal nodal mobility explain the low yield rates for transbronchial needle aspiration without real-time imaging? Chest (in press).
19. Chapet O, Kong FM, Quint LE, et al. CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan. Int J Radiat Oncol Biol Phys 2005;63:170-178.
20. Ahn SJ, Kahn D, Zhou S, et al. Dosimetric and clinical predictors for radiation-induced esophageal injury. Int J Radiat Oncol Biol Phys 2005;61:335-347.